spacer
spacer

PDBsum entry 1f0c

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Viral protein PDB id
1f0c

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
297 a.a. *
36 a.a. *
Ligands
DTT
Waters ×167
* Residue conservation analysis
PDB id:
1f0c
Name: Viral protein
Title: Structure of the viral serpin crma
Structure: Ice inhibitor. Chain: a. Fragment: residues 1-305. Synonym: cytokine response modifier protein, crma. Engineered: yes. Ice inhibitor. Chain: b. Fragment: residues 306-341. Synonym: cytokine response modifier protein, crma.
Source: Cowpox virus. Organism_taxid: 10243. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
Biol. unit: Dimer (from PQS)
Resolution:
2.26Å     R-factor:   0.228     R-free:   0.272
Authors: M.Renatus,Q.Zhou,H.R.Stennicke,S.J.Snipas,D.Turk,L.A.Bankston, R.C.Liddington,G.S.Salvesen
Key ref:
M.Renatus et al. (2000). Crystal structure of the apoptotic suppressor CrmA in its cleaved form. Structure, 8, 789-797. PubMed id: 10903953 DOI: 10.1016/S0969-2126(00)00165-9
Date:
15-May-00     Release date:   06-Sep-00    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P07385  (SPI2_CWPXB) -  Serine proteinase inhibitor 2 from Cowpox virus (strain Brighton Red)
Seq:
Struc:
341 a.a.
297 a.a.
Protein chain
Pfam   ArchSchema ?
P07385  (SPI2_CWPXB) -  Serine proteinase inhibitor 2 from Cowpox virus (strain Brighton Red)
Seq:
Struc:
341 a.a.
36 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains A, B: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1016/S0969-2126(00)00165-9 Structure 8:789-797 (2000)
PubMed id: 10903953  
 
 
Crystal structure of the apoptotic suppressor CrmA in its cleaved form.
M.Renatus, Q.Zhou, H.R.Stennicke, S.J.Snipas, D.Turk, L.A.Bankston, R.C.Liddington, G.S.Salvesen.
 
  ABSTRACT  
 
BACKGROUND: Cowpox virus expresses the serpin CrmA (cytokine response modifier A) in order to avoid inflammatory and apoptotic responses of infected host cells. The targets of CrmA are members of the caspase family of proteases that either initiate the extrinsic pathway of apoptosis (caspases 8 and 10) or trigger activation of the pro-inflammatory cytokines interleukin-1beta and interleukin-18 (caspase 1). RESULTS: We have determined the structure of a cleaved form of CrmA to 2.26 A resolution. CrmA has the typical fold of a cleaved serpin, even though it lacks the N-terminal half of the A helix, the entire D helix, and a portion of the E helix that are present in all other known serpins. The reactive-site loop of CrmA was mutated to contain the optimal substrate recognition sequence for caspase 3; however, the mutation only marginally increased the ability of CrmA to inhibit caspase 3. Superposition of the reactive-site loop of alpha1-proteinase inhibitor on the cleaved CrmA structure provides a model for virgin CrmA that can be docked to caspase 1, but not to caspase 3. CONCLUSIONS: CrmA exemplifies viral economy, selective pressure having resulted in a 'minimal' serpin that lacks the regions not needed for structural integrity or inhibitory activity. The docking model provides an explanation for the selectivity of CrmA. Our demonstration that engineering optimal substrate recognition sequences into the CrmA reactive-site loop fails to generate a good caspase 3 inhibitor is consistent with the docking model.
 
  Selected figure(s)  
 
Figure 4.
Figure 4. Stereoview of the electron density. Parts of the central b sheet A (strands 3A, 4A, 5A and 6A, right to left, and turn s5As4A) are superimposed with the final 2F[o]-F[c] electron-density map contoured at 0.8s. The atoms are colored by type: blue, carbon; cyan, nitrogen; and red, oxygen. The figure was made with the program BobScript [49].
 
  The above figure is reprinted by permission from Cell Press: Structure (2000, 8, 789-797) copyright 2000.  
  Figure was selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
18729734 S.M.Best (2008).
Viral subversion of apoptotic enzymes: escape from death row.
  Annu Rev Microbiol, 62, 171-192.  
17635906 L.D.Cabrita, J.A.Irving, M.C.Pearce, J.C.Whisstock, and S.P.Bottomley (2007).
Aeropin from the extremophile Pyrobaculum aerophilum bypasses the serpin misfolding trap.
  J Biol Chem, 282, 26802-26809.  
17142451 R.Swanson, M.P.Raghavendra, W.Zhang, C.Froelich, P.G.Gettins, and S.T.Olson (2007).
Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1.
  J Biol Chem, 282, 2305-2313.  
16977376 I.Chowdhury, B.Tharakan, and G.K.Bhat (2006).
Current concepts in apoptosis: the physiological suicide program revisited.
  Cell Mol Biol Lett, 11, 506-525.  
16338119 I.Millet, F.S.Wong, W.Gurr, L.Wen, W.Zawalich, E.A.Green, R.A.Flavell, and R.S.Sherwin (2006).
Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
  J Autoimmun, 26, 7.  
17052983 J.Dobó, R.Swanson, G.S.Salvesen, S.T.Olson, and P.G.Gettins (2006).
Cytokine response modifier a inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer.
  J Biol Chem, 281, 38781-38790.  
16737556 R.H.Law, Q.Zhang, S.McGowan, A.M.Buckle, G.A.Silverman, W.Wong, C.J.Rosado, C.G.Langendorf, R.N.Pike, P.I.Bird, and J.C.Whisstock (2006).
An overview of the serpin superfamily.
  Genome Biol, 7, 216.  
16200200 I.N.Lavrik, A.Golks, and P.H.Krammer (2005).
Caspases: pharmacological manipulation of cell death.
  J Clin Invest, 115, 2665-2672.  
15632287 L.D.Tesch, M.P.Raghavendra, T.Bedsted-Faarvang, P.G.Gettins, and S.T.Olson (2005).
Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
  Protein Sci, 14, 533-542.  
15117953 A.B.Werner, S.W.Tait, E.de Vries, E.Eldering, and J.Borst (2004).
Requirement for aspartate-cleaved bid in apoptosis signaling by DNA-damaging anti-cancer regimens.
  J Biol Chem, 279, 28771-28780.  
15638455 T.H.Roberts, J.Hejgaard, N.F.Saunders, R.Cavicchioli, and P.M.Curmi (2004).
Serpins in unicellular Eukarya, Archaea, and Bacteria: sequence analysis and evolution.
  J Mol Evol, 59, 437-447.  
12160859 H.Everett, and G.McFadden (2002).
Poxviruses and apoptosis: a time to die.
  Curr Opin Microbiol, 5, 395-402.  
11852247 H.R.Stennicke, C.A.Ryan, and G.S.Salvesen (2002).
Reprieval from execution: the molecular basis of caspase inhibition.
  Trends Biochem Sci, 27, 94.  
11290317 L.Goyal (2001).
Cell death inhibition: keeping caspases in check.
  Cell, 104, 805-808.  
11546761 L.Jankova, S.J.Harrop, D.N.Saunders, J.L.Andrews, K.C.Bertram, A.R.Gould, M.S.Baker, and P.M.Curmi (2001).
Crystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loop.
  J Biol Chem, 276, 43374-43382.
PDB code: 1jrr
11406281 Y.Suminami, F.Kishi, A.Murakami, Y.Sakaguchi, S.Nawata, F.Numa, and H.Kato (2001).
Novel forms of squamous cell carcinoma antigen transcripts produced by alternative splicing.
  Biochim Biophys Acta, 1519, 122-126.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer